Hiroomi Kanayama Selected Research

Hiroomi Kanayama Research Topics

Disease

9	Renal Cell Carcinoma (Grawitz Tumor) 03/2023 - 07/2007
8	Neoplasms (Cancer) 01/2023 - 12/2007
6	Prostatic Neoplasms (Prostate Cancer) 10/2022 - 03/2011
5	Neoplasm Metastasis (Metastasis) 04/2022 - 02/2010
5	Urinary Bladder Neoplasms (Bladder Cancer) 03/2017 - 04/2008
3	Carcinoma (Carcinomatosis) 02/2022 - 05/2016
2	Margins of Excision 01/2023 - 01/2021
2	Pain (Aches) 10/2017 - 11/2015
2	Diarrhea 10/2017 - 06/2013
1	Vesico-Ureteral Reflux (Vesicoureteral Reflux) 11/2022
1	Ureteral Obstruction 05/2022
1	COVID-19 01/2022
1	Anus Neoplasms (Anal Cancer) 01/2022
1	Urinary Bladder Fistula (Vesical Fistula) 01/2022
1	Fistula 01/2022
1	Hemorrhage 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Intraoperative Complications 01/2021
1	Disease Progression 11/2020
1	Thrombosis (Thrombus) 05/2018
1	Liposarcoma 05/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 10/2017
1	Fever (Fevers) 10/2017
1	Hematuria 10/2017
1	Cystitis 10/2017
1	Hypothyroidism 06/2013
1	Stomatitis 06/2013
1	Dysphonia (Spastic Dysphonia) 06/2013
1	Hypertension (High Blood Pressure) 06/2013
1	Hand-Foot Syndrome 06/2013
1	Anemia 09/2012
1	Solitary Kidney 07/2010

Drug/Important Bio-Agent (IBA)

3	cabozantinibIBA 03/2023 - 03/2017
3	Axitinib (AG 013736)IBA 01/2023 - 06/2013
3	Messenger RNA (mRNA)IBA 09/2013 - 02/2010
2	Tyrosine Kinase InhibitorsIBA 03/2023 - 11/2020
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2023 - 06/2013
2	NivolumabIBA 04/2022 - 10/2017
2	CytokinesIBA 12/2014 - 12/2007
2	AndrogensIBA 09/2013 - 06/2011
2	Thymidylate SynthaseIBA 09/2013 - 03/2011
2	Sorafenib (BAY 43-9006)FDA Link 06/2013 - 07/2010
2	Proteins (Proteins, Gene)FDA Link 01/2012 - 02/2010
2	Fluorouracil (Carac)FDA LinkGeneric 06/2011 - 03/2011
1	Biomarkers (Surrogate Marker)IBA 03/2023
1	Insulin ReceptorIBA 01/2023
1	4-azidosalicylic acid-phosphatidylserineIBA 11/2022
1	IpilimumabIBA 04/2022
1	PlatinumIBA 02/2022
1	avelumabIBA 02/2022
1	CA-19-9 Antigen (CA 19-9 Antigen)IBA 01/2022
1	AnticoagulantsIBA 01/2022
1	Carcinoembryonic AntigenIBA 01/2022
1	Prostate-Specific Antigen (Semenogelase)IBA 04/2021
1	Capsules (Microcapsules)IBA 04/2021
1	SteroidsIBA 10/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2017
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 03/2017
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 03/2017
1	Docetaxel (Taxotere)FDA Link 08/2015
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 12/2014
1	EnzymesIBA 09/2013
1	TegafurIBA 09/2013
1	Thymidine PhosphorylaseIBA 09/2013
1	UracilIBA 09/2013
1	Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA 09/2013
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2012
1	PlakophilinsIBA 01/2012
1	Insulin-Like PeptidesIBA 06/2011
1	Insulin-Like Growth Factor Binding Protein 3IBA 06/2011
1	Hormones (Hormone)IBA 03/2011
1	Androgen Receptors (Androgen Receptor)IBA 03/2011
1	hydroxyflutamideIBA 03/2011
1	bicalutamide (Casodex)FDA LinkGeneric 03/2011
1	Sunitinib (Sutent)FDA Link 07/2010
1	Microfilament Proteins (Actin Binding Proteins)IBA 02/2010
1	RNA (Ribonucleic Acid)IBA 02/2010

Therapy/Procedure

11	Therapeutics 03/2023 - 04/2008
5	Nephrectomy 01/2023 - 07/2010
4	Drug Therapy (Chemotherapy) 02/2022 - 04/2008
3	Castration 08/2015 - 06/2011
2	Warm Ischemia 01/2023 - 01/2021
2	Neoadjuvant Therapy 11/2022 - 07/2010
1	Length of Stay 01/2023
1	Sutures (Suture) 01/2023
1	Replantation 11/2022
1	Prostatectomy (Retropubic Prostatectomy) 10/2022
1	Stents 05/2022
1	Lasers (Laser) 05/2022
1	Conservative Treatment 01/2022
1	Blood Transfusion (Blood Transfusions) 01/2022
1	Colostomy 01/2022
1	Pelvic Exenteration 01/2022
1	Urinary Diversion (Ileal Conduit) 01/2022
1	Minimally Invasive Surgical Procedures 01/2022
1	Surgical Instruments (Clip) 01/2021
1	Molecular Targeted Therapy 07/2010
1	Radiotherapy 04/2008
1	Cystectomy 04/2008